The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Decongestant-Global Market Insights and Sales Trends 2025
Synopsis
Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.
The global Decongestant market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Decongestant in various end use industries. The expanding demands from the Hospitals, Research & Academic Laboratories, Clinic and Other, are propelling Decongestant market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Decongestant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Decongestant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Decongestant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Decongestant sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Decongestant covered in this report include Mylan N.V., Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Beximco Pharmaceuticals Ltd., Novartis AG and Cipla Ltd., etc.
The global Decongestant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
Global Decongestant market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Decongestant market, Segment by Type:
Tablets
Capsules
Nasal Sprays
Global Decongestant market, by Application
Hospitals
Research & Academic Laboratories
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Decongestant is a type of pharmaceutical drug that is used to relieve nasal congestion in the upper respiratory tract. The active ingredient in most decongestants is either pseudoephedrine or phenylephrine.
The global Decongestant market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Decongestant in various end use industries. The expanding demands from the Hospitals, Research & Academic Laboratories, Clinic and Other, are propelling Decongestant market. Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Decongestant, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Decongestant market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Decongestant market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Decongestant sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Decongestant covered in this report include Mylan N.V., Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Beximco Pharmaceuticals Ltd., Novartis AG and Cipla Ltd., etc.
The global Decongestant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
Global Decongestant market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Decongestant market, Segment by Type:
Tablets
Capsules
Nasal Sprays
Global Decongestant market, by Application
Hospitals
Research & Academic Laboratories
Clinic
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Decongestant Market Overview
1.1 Decongestant Product Overview
1.2 Decongestant Market Segment by Type
1.2.1 Tablets
1.2.2 Capsules
1.2.3 Nasal Sprays
1.3 Global Decongestant Market Size by Type
1.3.1 Global Decongestant Market Size Overview by Type (2018-2029)
1.3.2 Global Decongestant Historic Market Size Review by Type (2018-2023)
1.3.3 Global Decongestant Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Decongestant Sales Breakdown by Type (2018-2023)
1.4.2 Europe Decongestant Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Decongestant Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Decongestant Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Decongestant Sales Breakdown by Type (2018-2023)
2 Global Decongestant Market Competition by Company
2.1 Global Top Players by Decongestant Sales (2018-2023)
2.2 Global Top Players by Decongestant Revenue (2018-2023)
2.3 Global Top Players by Decongestant Price (2018-2023)
2.4 Global Top Manufacturers Decongestant Manufacturing Base Distribution, Sales Area, Product Type
2.5 Decongestant Market Competitive Situation and Trends
2.5.1 Decongestant Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Decongestant Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Decongestant as of 2022)
2.7 Date of Key Manufacturers Enter into Decongestant Market
2.8 Key Manufacturers Decongestant Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Decongestant Status and Outlook by Region
3.1 Global Decongestant Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Decongestant Historic Market Size by Region
3.2.1 Global Decongestant Sales in Volume by Region (2018-2023)
3.2.2 Global Decongestant Sales in Value by Region (2018-2023)
3.2.3 Global Decongestant Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Decongestant Forecasted Market Size by Region
3.3.1 Global Decongestant Sales in Volume by Region (2024-2029)
3.3.2 Global Decongestant Sales in Value by Region (2024-2029)
3.3.3 Global Decongestant Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Decongestant by Application
4.1 Decongestant Market Segment by Application
4.1.1 Hospitals
4.1.2 Research & Academic Laboratories
4.1.3 Clinic
4.1.4 Other
4.2 Global Decongestant Market Size by Application
4.2.1 Global Decongestant Market Size Overview by Application (2018-2029)
4.2.2 Global Decongestant Historic Market Size Review by Application (2018-2023)
4.2.3 Global Decongestant Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Decongestant Sales Breakdown by Application (2018-2023)
4.3.2 Europe Decongestant Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Decongestant Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Decongestant Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Decongestant Sales Breakdown by Application (2018-2023)
5 North America Decongestant by Country
5.1 North America Decongestant Historic Market Size by Country
5.1.1 North America Decongestant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Decongestant Sales in Volume by Country (2018-2023)
5.1.3 North America Decongestant Sales in Value by Country (2018-2023)
5.2 North America Decongestant Forecasted Market Size by Country
5.2.1 North America Decongestant Sales in Volume by Country (2024-2029)
5.2.2 North America Decongestant Sales in Value by Country (2024-2029)
6 Europe Decongestant by Country
6.1 Europe Decongestant Historic Market Size by Country
6.1.1 Europe Decongestant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Decongestant Sales in Volume by Country (2018-2023)
6.1.3 Europe Decongestant Sales in Value by Country (2018-2023)
6.2 Europe Decongestant Forecasted Market Size by Country
6.2.1 Europe Decongestant Sales in Volume by Country (2024-2029)
6.2.2 Europe Decongestant Sales in Value by Country (2024-2029)
7 Asia-Pacific Decongestant by Region
7.1 Asia-Pacific Decongestant Historic Market Size by Region
7.1.1 Asia-Pacific Decongestant Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Decongestant Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Decongestant Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Decongestant Forecasted Market Size by Region
7.2.1 Asia-Pacific Decongestant Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Decongestant Sales in Value by Region (2024-2029)
8 Latin America Decongestant by Country
8.1 Latin America Decongestant Historic Market Size by Country
8.1.1 Latin America Decongestant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Decongestant Sales in Volume by Country (2018-2023)
8.1.3 Latin America Decongestant Sales in Value by Country (2018-2023)
8.2 Latin America Decongestant Forecasted Market Size by Country
8.2.1 Latin America Decongestant Sales in Volume by Country (2024-2029)
8.2.2 Latin America Decongestant Sales in Value by Country (2024-2029)
9 Middle East and Africa Decongestant by Country
9.1 Middle East and Africa Decongestant Historic Market Size by Country
9.1.1 Middle East and Africa Decongestant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Decongestant Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Decongestant Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Decongestant Forecasted Market Size by Country
9.2.1 Middle East and Africa Decongestant Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Decongestant Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mylan N.V.
10.1.1 Mylan N.V. Company Information
10.1.2 Mylan N.V. Introduction and Business Overview
10.1.3 Mylan N.V. Decongestant Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mylan N.V. Decongestant Products Offered
10.1.5 Mylan N.V. Recent Development
10.2 Teva Pharmaceutical Industries Ltd.
10.2.1 Teva Pharmaceutical Industries Ltd. Company Information
10.2.2 Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
10.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Pharmaceutical Industries Ltd. Decongestant Products Offered
10.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.3 Ranbaxy Laboratories Ltd.
10.3.1 Ranbaxy Laboratories Ltd. Company Information
10.3.2 Ranbaxy Laboratories Ltd. Introduction and Business Overview
10.3.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ranbaxy Laboratories Ltd. Decongestant Products Offered
10.3.5 Ranbaxy Laboratories Ltd. Recent Development
10.4 Beximco Pharmaceuticals Ltd.
10.4.1 Beximco Pharmaceuticals Ltd. Company Information
10.4.2 Beximco Pharmaceuticals Ltd. Introduction and Business Overview
10.4.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Beximco Pharmaceuticals Ltd. Decongestant Products Offered
10.4.5 Beximco Pharmaceuticals Ltd. Recent Development
10.5 Novartis AG
10.5.1 Novartis AG Company Information
10.5.2 Novartis AG Introduction and Business Overview
10.5.3 Novartis AG Decongestant Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novartis AG Decongestant Products Offered
10.5.5 Novartis AG Recent Development
10.6 Cipla Ltd.
10.6.1 Cipla Ltd. Company Information
10.6.2 Cipla Ltd. Introduction and Business Overview
10.6.3 Cipla Ltd. Decongestant Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cipla Ltd. Decongestant Products Offered
10.6.5 Cipla Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Decongestant Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Decongestant Industrial Chain Analysis
11.4 Decongestant Market Dynamics
11.4.1 Decongestant Industry Trends
11.4.2 Decongestant Market Drivers
11.4.3 Decongestant Market Challenges
11.4.4 Decongestant Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Decongestant Distributors
12.3 Decongestant Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
